Subjects with high fasting insulin also have higher postprandial GLP-1 and glucagon levels than controls with lower insulin

Little is known about postprandial release of serum ghrelin, glucagon, and glucagon-like peptide-1 (GLP-1) in relation with differing fasting insulin levels. We hypothesized that these hormones are affected by insulin resistance, and hence, we compared different postprandial responses of GLP-1, gluc...

Full description

Saved in:
Bibliographic Details
Published inNutrition research (New York, N.Y.) Vol. 72; pp. 111 - 120
Main Authors Albinsson-Stenholm, Erina, Bergsén, Johannes, Ingves, Simon, Vilhelmsson, Nathalie, Guldbrand, Hans, Nystrom, Fredrik H
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2019
Subjects
Online AccessGet full text
ISSN0271-5317
1879-0739
1879-0739
DOI10.1016/j.nutres.2019.10.009

Cover

Abstract Little is known about postprandial release of serum ghrelin, glucagon, and glucagon-like peptide-1 (GLP-1) in relation with differing fasting insulin levels. We hypothesized that these hormones are affected by insulin resistance, and hence, we compared different postprandial responses of GLP-1, glucagon, and ghrelin in subjects with relatively high (RHI) or relatively low (RLI) fasting insulin levels. The trial was a randomized crossover study with 4 different meal conditions. Fourteen nonobese or obese, healthy, men and 14 women were randomly assigned to the order of supervised intake of a 750 kcal drink with the same protein contents but with 20 energy-percent (E%) or 55 E% from carbohydrates, and the remaining energy from fat. Participants were also randomized to consume the drinks as 1 large beverage or as five 150-kcal portions every 30 minutes. The 28 subjects were divided into 2 equally sized groups based on fasting insulin levels. Statistics were done with general linear mixed model. Fasting insulin levels were 3-fold higher in the group with RHI compared with the RLI group (RHI: 1004 ± 510 pg/mL, RLI: 324 ± 123 pg/mL, P < .0005). Serum GLP-1 was highest in the RHI group after both single meals and after 5 drinks and following high- and low-carbohydrate meals (both P ≤ .002), and this was the case also for glucagon levels (both P ≤ .018), whereas ghrelin levels did not differ between groups. Thus, subjects with RHI displayed both higher postprandial serum GLP-1 and glucagon than the participants with RLI, suggesting that glucagon could play a role in the advent of dysglycemia by insulin resistance.
AbstractList Little is known about postprandial release of serum ghrelin, glucagon, and glucagon-like peptide-1 (GLP-1) in relation with differing fasting insulin levels. We hypothesized that these hormones are affected by insulin resistance, and hence, we compared different postprandial responses of GLP-1, glucagon, and ghrelin in subjects with relatively high (RHI) or relatively low (RLI) fasting insulin levels. The trial was a randomized crossover study with 4 different meal conditions. Fourteen nonobese or obese, healthy, men and 14 women were randomly assigned to the order of supervised intake of a 750 kcal drink with the same protein contents but with 20 energy-percent (E%) or 55 E% from carbohydrates, and the remaining energy from fat. Participants were also randomized to consume the drinks as 1 large beverage or as five 150-kcal portions every 30 minutes. The 28 subjects were divided into 2 equally sized groups based on fasting insulin levels. Statistics were done with general linear mixed model. Fasting insulin levels were 3-fold higher in the group with RHI compared with the RLI group (RHI: 1004 ± 510 pg/mL, RLI: 324 ± 123 pg/mL, P < .0005). Serum GLP-1 was highest in the RHI group after both single meals and after 5 drinks and following high- and low-carbohydrate meals (both P ≤ .002), and this was the case also for glucagon levels (both P ≤ .018), whereas ghrelin levels did not differ between groups. Thus, subjects with RHI displayed both higher postprandial serum GLP-1 and glucagon than the participants with RLI, suggesting that glucagon could play a role in the advent of dysglycemia by insulin resistance.
Little is known about postprandial release of serum ghrelin, glucagon, and glucagon-like peptide-1 (GLP-1) in relation with differing fasting insulin levels. We hypothesized that these hormones are affected by insulin resistance, and hence, we compared different postprandial responses of GLP-1, glucagon, and ghrelin in subjects with relatively high (RHI) or relatively low (RLI) fasting insulin levels. The trial was a randomized crossover study with 4 different meal conditions. Fourteen nonobese or obese, healthy, men and 14 women were randomly assigned to the order of supervised intake of a 750 kcal drink with the same protein contents but with 20 energy-percent (E%) or 55 E% from carbohydrates, and the remaining energy from fat. Participants were also randomized to consume the drinks as 1 large beverage or as five 150-kcal portions every 30 minutes. The 28 subjects were divided into 2 equally sized groups based on fasting insulin levels. Statistics were done with general linear mixed model. Fasting insulin levels were 3-fold higher in the group with RHI compared with the RLI group (RHI: 1004 +/- 510 pg/mL, RLI: 324 +/- 123 pg/mL, P amp;lt; .0005). Serum GLP-1 was highest in the RHI group after both single meals and after 5 drinks and following high- and low-carbohydrate meals (both P amp;lt;= .002), and this was the case also for glucagon levels (both P amp;lt;= .018), whereas ghrelin levels did not differ between groups. Thus, subjects with RHI displayed both higher postprandial serum GLP-1 and glucagon than the participants with RLI, suggesting that glucagon could play a role in the advent of dysglycemia by insulin resistance. (C) 2019 Elsevier Inc. All rights reserved.
Little is known about postprandial release of serum ghrelin, glucagon, and glucagon-like peptide-1 (GLP-1) in relation with differing fasting insulin levels. We hypothesized that these hormones are affected by insulin resistance, and hence, we compared different postprandial responses of GLP-1, glucagon, and ghrelin in subjects with relatively high (RHI) or relatively low (RLI) fasting insulin levels. The trial was a randomized crossover study with 4 different meal conditions. Fourteen nonobese or obese, healthy, men and 14 women were randomly assigned to the order of supervised intake of a 750 kcal drink with the same protein contents but with 20 energy-percent (E%) or 55 E% from carbohydrates, and the remaining energy from fat. Participants were also randomized to consume the drinks as 1 large beverage or as five 150-kcal portions every 30 minutes. The 28 subjects were divided into 2 equally sized groups based on fasting insulin levels. Statistics were done with general linear mixed model. Fasting insulin levels were 3-fold higher in the group with RHI compared with the RLI group (RHI: 1004 ± 510 pg/mL, RLI: 324 ± 123 pg/mL, P < .0005). Serum GLP-1 was highest in the RHI group after both single meals and after 5 drinks and following high- and low-carbohydrate meals (both P ≤ .002), and this was the case also for glucagon levels (both P ≤ .018), whereas ghrelin levels did not differ between groups. Thus, subjects with RHI displayed both higher postprandial serum GLP-1 and glucagon than the participants with RLI, suggesting that glucagon could play a role in the advent of dysglycemia by insulin resistance.Little is known about postprandial release of serum ghrelin, glucagon, and glucagon-like peptide-1 (GLP-1) in relation with differing fasting insulin levels. We hypothesized that these hormones are affected by insulin resistance, and hence, we compared different postprandial responses of GLP-1, glucagon, and ghrelin in subjects with relatively high (RHI) or relatively low (RLI) fasting insulin levels. The trial was a randomized crossover study with 4 different meal conditions. Fourteen nonobese or obese, healthy, men and 14 women were randomly assigned to the order of supervised intake of a 750 kcal drink with the same protein contents but with 20 energy-percent (E%) or 55 E% from carbohydrates, and the remaining energy from fat. Participants were also randomized to consume the drinks as 1 large beverage or as five 150-kcal portions every 30 minutes. The 28 subjects were divided into 2 equally sized groups based on fasting insulin levels. Statistics were done with general linear mixed model. Fasting insulin levels were 3-fold higher in the group with RHI compared with the RLI group (RHI: 1004 ± 510 pg/mL, RLI: 324 ± 123 pg/mL, P < .0005). Serum GLP-1 was highest in the RHI group after both single meals and after 5 drinks and following high- and low-carbohydrate meals (both P ≤ .002), and this was the case also for glucagon levels (both P ≤ .018), whereas ghrelin levels did not differ between groups. Thus, subjects with RHI displayed both higher postprandial serum GLP-1 and glucagon than the participants with RLI, suggesting that glucagon could play a role in the advent of dysglycemia by insulin resistance.
Author Nystrom, Fredrik H
Vilhelmsson, Nathalie
Albinsson-Stenholm, Erina
Bergsén, Johannes
Ingves, Simon
Guldbrand, Hans
Author_xml – sequence: 1
  givenname: Erina
  surname: Albinsson-Stenholm
  fullname: Albinsson-Stenholm, Erina
– sequence: 2
  givenname: Johannes
  surname: Bergsén
  fullname: Bergsén, Johannes
– sequence: 3
  givenname: Simon
  surname: Ingves
  fullname: Ingves, Simon
– sequence: 4
  givenname: Nathalie
  surname: Vilhelmsson
  fullname: Vilhelmsson, Nathalie
– sequence: 5
  givenname: Hans
  surname: Guldbrand
  fullname: Guldbrand, Hans
– sequence: 6
  givenname: Fredrik H
  surname: Nystrom
  fullname: Nystrom, Fredrik H
  email: fredrik.h.nystrom@liu.se, Fredrik.h.nystrom@gmail.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31759769$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-163259$$DView record from Swedish Publication Index
BookMark eNqNkl1vFCEUhompsdvqPzCGS29mBeaDHWNMmmqrySaa-HFLGObMDCsLIzC7afzzZZ2tF71ZrwiH931CeLhAZ9ZZQOglJUtKaPVms7RT9BCWjNA6jZaE1E_Qgq54nRGe12doQRinWZlTfo4uQtgQQjnN82foPI3Kmlf1Av35NjUbUDHgvY4DHnQ_4E6GqG2PtQ2T0RZLExwe5A7-HoPHowtx9NK2Whp8u_6aUZw2uDeTkr2z2MAOTMBxkBYrZ6N35sg3bp_6R_Bz9LRLbHhxXC_Rj5uP368_Zesvt5-vr9aZKnMWs46UspSdLGAFhBZsVfCqU7KiqlEtZV3O6g5WRVUoVqmuoSXt8po1RBUsJzw9xSXKZm7Ywzg1YvR6K_2dcFKLD_rnlXC-F0ZPglY5K-uUfz3nR-9-TxCi2OqgwBhpwU1BsLxkRVFyQv8jSnnNacmLFH11jE7NFtp_t3hwkQJv54DyLgQPnVA6yqgPDyi1EZSIg3ixEbN4cRB_mCbxqVw8Kj_wT9Tez7XkC3YavAhKg1XQap9-hWidPgV49wigklmtpPkFd6fr92OD360
CitedBy_id crossref_primary_10_3390_ijms24108937
Cites_doi 10.1111/dom.12935
10.1038/ejcn.2014.208
10.1155/2010/710852
10.1002/dmrr.2501
10.3945/ajcn.115.106799
10.1210/jc.2013-4010
10.1016/j.peptides.2017.12.015
10.1080/07435800.2017.1379023
10.1016/j.nut.2014.10.002
10.1016/S2213-8587(15)00482-9
10.1016/j.biochi.2017.10.004
10.1097/MCO.0000000000000101
10.1055/a-0746-4014
10.4239/wjd.v7.i20.572
10.3390/molecules23061483
10.1111/j.2040-1124.2010.00022.x
10.3109/13813455.2013.812664
10.1016/j.peptides.2017.04.011
10.1056/NEJM199205143262003
10.1530/EJE-19-0173
10.1038/nutd.2013.20
10.14310/horm.2002.1672
10.1136/bmj.k4583
10.1507/endocrj.K09E-269
10.1042/CS20150154
10.1016/j.mayocp.2017.12.003
10.1038/s41574-018-0016-2
10.1186/s12933-016-0440-3
10.2337/db16-0240
10.1016/j.peptides.2017.11.016
ContentType Journal Article
Copyright 2019 Elsevier Inc.
Copyright © 2019 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2019 Elsevier Inc.
– notice: Copyright © 2019 Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
NPM
7X8
7S9
L.6
ABXSW
ADTPV
AOWAS
D8T
DG8
ZZAVC
DOI 10.1016/j.nutres.2019.10.009
DatabaseName CrossRef
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
SWEPUB Linköpings universitet full text
SwePub
SwePub Articles
SWEPUB Freely available online
SWEPUB Linköpings universitet
SwePub Articles full text
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList PubMed

AGRICOLA


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Diet & Clinical Nutrition
Statistics
EISSN 1879-0739
EndPage 120
ExternalDocumentID oai_DiVA_org_liu_163259
31759769
10_1016_j_nutres_2019_10_009
S0271531719305214
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29N
4.4
457
4CK
4G.
53G
5RE
5VS
7-5
71M
85S
8P~
9JM
AAEDT
AAEDW
AAHBH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABGSF
ABJNI
ABMAC
ABMZM
ABUDA
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADUVX
AEBSH
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDZ
HMK
HMO
HVGLF
HZ~
IHE
J1W
K-O
KOM
LZ1
M29
M41
MO0
MVM
N9A
O-L
O9-
OAUVE
OC.
ON0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
WH7
WUQ
Z5R
ZGI
ZXP
~G-
~KM
AACTN
AAIAV
ABLVK
ABYKQ
AFCTW
AFKWA
AJBFU
AJOXV
AMFUW
DOVZS
EFLBG
LCYCR
AAYXX
AGRNS
CITATION
NPM
7X8
ACLOT
~HD
7S9
L.6
ABXSW
ADTPV
AOWAS
D8T
DG8
ZZAVC
ID FETCH-LOGICAL-c532t-f05a5afa4e8e01428476fca61cbcd12f329fe8464c26cfb151f392b0c42307073
IEDL.DBID .~1
ISSN 0271-5317
1879-0739
IngestDate Tue Sep 09 23:08:23 EDT 2025
Sun Sep 28 07:40:20 EDT 2025
Sat Sep 27 19:31:33 EDT 2025
Wed Feb 19 02:32:17 EST 2025
Thu Apr 24 22:49:24 EDT 2025
Tue Jul 01 03:50:15 EDT 2025
Fri Feb 23 02:49:21 EST 2024
Tue Aug 26 18:28:03 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Meal distribution
EE
GLP-1
Glucagon
RLI
AUC
Glucagon-like peptide-1
RHI
Ghrelin
LC
Satiety
SEM
HC
Carbohydrate content
BMI
Language English
License Copyright © 2019 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c532t-f05a5afa4e8e01428476fca61cbcd12f329fe8464c26cfb151f392b0c42307073
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-163259
PMID 31759769
PQID 2317971574
PQPubID 23479
PageCount 10
ParticipantIDs swepub_primary_oai_DiVA_org_liu_163259
proquest_miscellaneous_2352445701
proquest_miscellaneous_2317971574
pubmed_primary_31759769
crossref_citationtrail_10_1016_j_nutres_2019_10_009
crossref_primary_10_1016_j_nutres_2019_10_009
elsevier_sciencedirect_doi_10_1016_j_nutres_2019_10_009
elsevier_clinicalkey_doi_10_1016_j_nutres_2019_10_009
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-12-01
PublicationDateYYYYMMDD 2019-12-01
PublicationDate_xml – month: 12
  year: 2019
  text: 2019-12-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Nutrition research (New York, N.Y.)
PublicationTitleAlternate Nutr Res
PublicationYear 2019
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Faerch, Vistisen, Pacini, Torekov, Johansen, Witte (bb0115) 2016; 65
Andersen, Lund, Knop, Vilsboll (bb0030) 2018; 14
Ceriello, Genovese, Mannucci, Gronda (bb0085) 2016; 15
Girard (bb0070) 2017; 143
Gutniak, Orskov, Holst, Ahren, Efendic (bb0120) 1992; 326
Mihalache, Gherasim, Nita, Ungureanu, Padureanu, Gavril (bb0055) 2016; 15
Temizkan, Deyneli, Yasar, Arpa, Gunes, Yazici (bb0020) 2015; 69
Seino, Fukushima, Yabe (bb0100) 2010; 1
van Raalte, Verchere (bb0005) 2017; 19
Prodam, Monzani, Ricotti, Marolda, Bellone, Aimaretti (bb0045) 2014; 99
Jezek, Jaburek, Holendova, Plecita-Hlavata (bb0010) 2018; 23
Benedict, Barclay, Ott, Oster, Hallschmid (bb0155) 2013; 3
Lee, Yabe, Nohtomi, Takada, Morita, Seino (bb0105) 2010; 57
Urbano, Di Pino, Scicali, Filippello, Di Mauro, Scamporrino (bb0125) 2019
Koliaki, Kokkinos, Tentolouris, Katsilambros (bb0060) 2010; 2010
Pinkney (bb0050) 2014; 17
Mandoe, Hansen, Hartmann, Rehfeld, Holst, Hansen (bb0015) 2015; 102
Bounias, Pouliliou, Tripsianis, Antonoglou, Papazoglou, Maltezos (bb0110) 2018; 50
Ingves, Vilhelmsson, Strom, Fredrikson, Guldbrand, Nystrom (bb0090) 2017; 93
Haedersdal, Lund, Knop, Vilsboll (bb0075) 2018; 93
Malik, Roohi (bb0135) 2018; 32
Anandhakrishnan, Korbonits (bb0025) 2016; 7
Nauck, Meier (bb0040) 2016; 4
Kuhre, Holst, Kappe (bb0140) 2016; 130
Nystrom, Quon (bb0145) 2015; 31
Ebbeling, Feldman, Klein, Wong, Bielak, Steltz (bb0150) 2018; 363
Yoo, Yang, Lee, Koh (bb0095) 2018; 43
Tasyurek, Altunbas, Balci, Sanlioglu (bb0035) 2014; 30
Wewer Albrechtsen (bb0080) 2018; 100
Poher, Tschop, Muller (bb0065) 2018; 100
Opinto, Natalicchio, Marchetti (bb0130) 2013; 119
Poher (10.1016/j.nutres.2019.10.009_bb0065) 2018; 100
Girard (10.1016/j.nutres.2019.10.009_bb0070) 2017; 143
Seino (10.1016/j.nutres.2019.10.009_bb0100) 2010; 1
Pinkney (10.1016/j.nutres.2019.10.009_bb0050) 2014; 17
Haedersdal (10.1016/j.nutres.2019.10.009_bb0075) 2018; 93
Ceriello (10.1016/j.nutres.2019.10.009_bb0085) 2016; 15
Wewer Albrechtsen (10.1016/j.nutres.2019.10.009_bb0080) 2018; 100
Anandhakrishnan (10.1016/j.nutres.2019.10.009_bb0025) 2016; 7
Mihalache (10.1016/j.nutres.2019.10.009_bb0055) 2016; 15
Andersen (10.1016/j.nutres.2019.10.009_bb0030) 2018; 14
Opinto (10.1016/j.nutres.2019.10.009_bb0130) 2013; 119
Faerch (10.1016/j.nutres.2019.10.009_bb0115) 2016; 65
Yoo (10.1016/j.nutres.2019.10.009_bb0095) 2018; 43
Prodam (10.1016/j.nutres.2019.10.009_bb0045) 2014; 99
Urbano (10.1016/j.nutres.2019.10.009_bb0125) 2019
van Raalte (10.1016/j.nutres.2019.10.009_bb0005) 2017; 19
Gutniak (10.1016/j.nutres.2019.10.009_bb0120) 1992; 326
Nystrom (10.1016/j.nutres.2019.10.009_bb0145) 2015; 31
Ebbeling (10.1016/j.nutres.2019.10.009_bb0150) 2018; 363
Tasyurek (10.1016/j.nutres.2019.10.009_bb0035) 2014; 30
Ingves (10.1016/j.nutres.2019.10.009_bb0090) 2017; 93
Bounias (10.1016/j.nutres.2019.10.009_bb0110) 2018; 50
Malik (10.1016/j.nutres.2019.10.009_bb0135) 2018; 32
Benedict (10.1016/j.nutres.2019.10.009_bb0155) 2013; 3
Kuhre (10.1016/j.nutres.2019.10.009_bb0140) 2016; 130
Jezek (10.1016/j.nutres.2019.10.009_bb0010) 2018; 23
Temizkan (10.1016/j.nutres.2019.10.009_bb0020) 2015; 69
Koliaki (10.1016/j.nutres.2019.10.009_bb0060) 2010; 2010
Mandoe (10.1016/j.nutres.2019.10.009_bb0015) 2015; 102
Nauck (10.1016/j.nutres.2019.10.009_bb0040) 2016; 4
Lee (10.1016/j.nutres.2019.10.009_bb0105) 2010; 57
References_xml – volume: 130
  start-page: 79
  year: 2016
  end-page: 91
  ident: bb0140
  article-title: The regulation of function, growth and survival of GLP-1-producing L-cells
  publication-title: Clin Sci (Lond)
– volume: 50
  start-page: 822
  year: 2018
  end-page: 826
  ident: bb0110
  article-title: Ghrelin levels in basal conditions and during glucose tolerance test in prediabetic and diabetic patients
  publication-title: Horm Metab Res
– volume: 14
  start-page: 390
  year: 2018
  end-page: 403
  ident: bb0030
  article-title: Glucagon-like peptide 1 in health and disease
  publication-title: Nat Rev Endocrinol
– volume: 99
  start-page: 1556
  year: 2014
  end-page: 1568
  ident: bb0045
  article-title: Systematic review of ghrelin response to food intake in pediatric age, from neonates to adolescents
  publication-title: J Clin Endocrinol Metab
– volume: 31
  start-page: 244
  year: 2015
  end-page: 247
  ident: bb0145
  article-title: Man shall not live by bread alone
  publication-title: Nutrition
– volume: 32
  start-page: 1171
  year: 2018
  end-page: 1176
  ident: bb0135
  article-title: GLP-1, a powerful physiological incretin: an update
  publication-title: J Biol Regul Homeost Agents
– volume: 65
  start-page: 3473
  year: 2016
  end-page: 3481
  ident: bb0115
  article-title: Insulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation
  publication-title: Diabetes
– volume: 17
  start-page: 497
  year: 2014
  end-page: 502
  ident: bb0050
  article-title: The role of ghrelin in metabolic regulation
  publication-title: Curr Opin Clin Nutr Metab Care
– volume: 23
  year: 2018
  ident: bb0010
  article-title: Fatty acid-stimulated insulin secretion vs. Lipotoxicity
  publication-title: Molecules
– volume: 1
  start-page: 8
  year: 2010
  end-page: 23
  ident: bb0100
  article-title: GIP and GLP-1, the two incretin hormones: similarities and differences
  publication-title: J Diabetes Investig
– volume: 93
  start-page: 217
  year: 2018
  end-page: 239
  ident: bb0075
  article-title: The role of glucagon in the pathophysiology and treatment of type 2 diabetes
  publication-title: Mayo Clin Proc
– volume: 57
  start-page: 119
  year: 2010
  end-page: 126
  ident: bb0105
  article-title: Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes
  publication-title: Endocr J
– volume: 69
  start-page: 162
  year: 2015
  end-page: 166
  ident: bb0020
  article-title: Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in patients with type 2 diabetes
  publication-title: Eur J Clin Nutr
– volume: 93
  start-page: 20
  year: 2017
  end-page: 26
  ident: bb0090
  article-title: A randomized cross-over study of the effects of macronutrient composition and meal frequency on GLP-1, ghrelin and energy expenditure in humans
  publication-title: Peptides
– volume: 119
  start-page: 170
  year: 2013
  end-page: 178
  ident: bb0130
  article-title: Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity
  publication-title: Arch Physiol Biochem
– volume: 3
  start-page: e78
  year: 2013
  ident: bb0155
  article-title: Acute sleep deprivation delays the glucagon-like peptide 1 peak response to breakfast in healthy men
  publication-title: Nutr Diabetes
– volume: 7
  start-page: 572
  year: 2016
  end-page: 598
  ident: bb0025
  article-title: Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity
  publication-title: World J Diabetes
– year: 2019
  ident: bb0125
  article-title: Impaired glucagon suppression and reduced insulin sensitivity in subjects with prediabetes undergoing atorvastatin therapy
  publication-title: Eur J Endocrinol
– volume: 43
  start-page: 47
  year: 2018
  end-page: 54
  ident: bb0095
  article-title: Postmeal increment in intact glucagon-like peptide 1 level, but not intact glucose-dependent insulinotropic polypeptide levels, is inversely associated with metabolic syndrome in patients with type 2 diabetes
  publication-title: Endocr Res
– volume: 102
  start-page: 548
  year: 2015
  end-page: 555
  ident: bb0015
  article-title: The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans
  publication-title: Am J Clin Nutr
– volume: 15
  start-page: 186
  year: 2016
  end-page: 196
  ident: bb0055
  article-title: Effects of ghrelin in energy balance and body weight homeostasis
  publication-title: Hormones (Athens)
– volume: 363
  start-page: k4583
  year: 2018
  ident: bb0150
  article-title: Effects of a low carbohydrate diet on energy expenditure during weight loss maintenance: randomized trial
  publication-title: BMJ
– volume: 2010
  year: 2010
  ident: bb0060
  article-title: The effect of ingested macronutrients on postprandial ghrelin response: a critical review of existing literature data
  publication-title: Int J Pept
– volume: 326
  start-page: 1316
  year: 1992
  end-page: 1322
  ident: bb0120
  article-title: Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus
  publication-title: N Engl J Med
– volume: 19
  start-page: 1205
  year: 2017
  end-page: 1213
  ident: bb0005
  article-title: Improving glycaemic control in type 2 diabetes: stimulate insulin secretion or provide beta-cell rest?
  publication-title: Diabetes Obes Metab
– volume: 100
  start-page: 236
  year: 2018
  end-page: 242
  ident: bb0065
  article-title: Ghrelin regulation of glucose metabolism
  publication-title: Peptides
– volume: 30
  start-page: 354
  year: 2014
  end-page: 371
  ident: bb0035
  article-title: Incretins: their physiology and application in the treatment of diabetes mellitus
  publication-title: Diabetes Metab Res Rev
– volume: 100
  start-page: 42
  year: 2018
  end-page: 47
  ident: bb0080
  article-title: Glucagon receptor signaling in metabolic diseases
  publication-title: Peptides
– volume: 15
  start-page: 123
  year: 2016
  ident: bb0085
  article-title: Glucagon and heart in type 2 diabetes: new perspectives
  publication-title: Cardiovasc Diabetol
– volume: 4
  start-page: 525
  year: 2016
  end-page: 536
  ident: bb0040
  article-title: The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions
  publication-title: Lancet Diabetes Endocrinol
– volume: 143
  start-page: 33
  year: 2017
  end-page: 36
  ident: bb0070
  article-title: Glucagon, a key factor in the pathophysiology of type 2 diabetes
  publication-title: Biochimie
– volume: 19
  start-page: 1205
  year: 2017
  ident: 10.1016/j.nutres.2019.10.009_bb0005
  article-title: Improving glycaemic control in type 2 diabetes: stimulate insulin secretion or provide beta-cell rest?
  publication-title: Diabetes Obes Metab
  doi: 10.1111/dom.12935
– volume: 69
  start-page: 162
  year: 2015
  ident: 10.1016/j.nutres.2019.10.009_bb0020
  article-title: Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in patients with type 2 diabetes
  publication-title: Eur J Clin Nutr
  doi: 10.1038/ejcn.2014.208
– volume: 2010
  year: 2010
  ident: 10.1016/j.nutres.2019.10.009_bb0060
  article-title: The effect of ingested macronutrients on postprandial ghrelin response: a critical review of existing literature data
  publication-title: Int J Pept
  doi: 10.1155/2010/710852
– volume: 30
  start-page: 354
  year: 2014
  ident: 10.1016/j.nutres.2019.10.009_bb0035
  article-title: Incretins: their physiology and application in the treatment of diabetes mellitus
  publication-title: Diabetes Metab Res Rev
  doi: 10.1002/dmrr.2501
– volume: 102
  start-page: 548
  year: 2015
  ident: 10.1016/j.nutres.2019.10.009_bb0015
  article-title: The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans
  publication-title: Am J Clin Nutr
  doi: 10.3945/ajcn.115.106799
– volume: 99
  start-page: 1556
  year: 2014
  ident: 10.1016/j.nutres.2019.10.009_bb0045
  article-title: Systematic review of ghrelin response to food intake in pediatric age, from neonates to adolescents
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2013-4010
– volume: 100
  start-page: 236
  year: 2018
  ident: 10.1016/j.nutres.2019.10.009_bb0065
  article-title: Ghrelin regulation of glucose metabolism
  publication-title: Peptides
  doi: 10.1016/j.peptides.2017.12.015
– volume: 43
  start-page: 47
  year: 2018
  ident: 10.1016/j.nutres.2019.10.009_bb0095
  article-title: Postmeal increment in intact glucagon-like peptide 1 level, but not intact glucose-dependent insulinotropic polypeptide levels, is inversely associated with metabolic syndrome in patients with type 2 diabetes
  publication-title: Endocr Res
  doi: 10.1080/07435800.2017.1379023
– volume: 31
  start-page: 244
  year: 2015
  ident: 10.1016/j.nutres.2019.10.009_bb0145
  article-title: Man shall not live by bread alone
  publication-title: Nutrition
  doi: 10.1016/j.nut.2014.10.002
– volume: 4
  start-page: 525
  year: 2016
  ident: 10.1016/j.nutres.2019.10.009_bb0040
  article-title: The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(15)00482-9
– volume: 143
  start-page: 33
  year: 2017
  ident: 10.1016/j.nutres.2019.10.009_bb0070
  article-title: Glucagon, a key factor in the pathophysiology of type 2 diabetes
  publication-title: Biochimie
  doi: 10.1016/j.biochi.2017.10.004
– volume: 17
  start-page: 497
  year: 2014
  ident: 10.1016/j.nutres.2019.10.009_bb0050
  article-title: The role of ghrelin in metabolic regulation
  publication-title: Curr Opin Clin Nutr Metab Care
  doi: 10.1097/MCO.0000000000000101
– volume: 50
  start-page: 822
  year: 2018
  ident: 10.1016/j.nutres.2019.10.009_bb0110
  article-title: Ghrelin levels in basal conditions and during glucose tolerance test in prediabetic and diabetic patients
  publication-title: Horm Metab Res
  doi: 10.1055/a-0746-4014
– volume: 7
  start-page: 572
  year: 2016
  ident: 10.1016/j.nutres.2019.10.009_bb0025
  article-title: Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity
  publication-title: World J Diabetes
  doi: 10.4239/wjd.v7.i20.572
– volume: 23
  year: 2018
  ident: 10.1016/j.nutres.2019.10.009_bb0010
  article-title: Fatty acid-stimulated insulin secretion vs. Lipotoxicity
  publication-title: Molecules
  doi: 10.3390/molecules23061483
– volume: 1
  start-page: 8
  year: 2010
  ident: 10.1016/j.nutres.2019.10.009_bb0100
  article-title: GIP and GLP-1, the two incretin hormones: similarities and differences
  publication-title: J Diabetes Investig
  doi: 10.1111/j.2040-1124.2010.00022.x
– volume: 119
  start-page: 170
  year: 2013
  ident: 10.1016/j.nutres.2019.10.009_bb0130
  article-title: Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity
  publication-title: Arch Physiol Biochem
  doi: 10.3109/13813455.2013.812664
– volume: 93
  start-page: 20
  year: 2017
  ident: 10.1016/j.nutres.2019.10.009_bb0090
  article-title: A randomized cross-over study of the effects of macronutrient composition and meal frequency on GLP-1, ghrelin and energy expenditure in humans
  publication-title: Peptides
  doi: 10.1016/j.peptides.2017.04.011
– volume: 326
  start-page: 1316
  year: 1992
  ident: 10.1016/j.nutres.2019.10.009_bb0120
  article-title: Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199205143262003
– year: 2019
  ident: 10.1016/j.nutres.2019.10.009_bb0125
  article-title: Impaired glucagon suppression and reduced insulin sensitivity in subjects with prediabetes undergoing atorvastatin therapy
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-19-0173
– volume: 3
  start-page: e78
  year: 2013
  ident: 10.1016/j.nutres.2019.10.009_bb0155
  article-title: Acute sleep deprivation delays the glucagon-like peptide 1 peak response to breakfast in healthy men
  publication-title: Nutr Diabetes
  doi: 10.1038/nutd.2013.20
– volume: 15
  start-page: 186
  year: 2016
  ident: 10.1016/j.nutres.2019.10.009_bb0055
  article-title: Effects of ghrelin in energy balance and body weight homeostasis
  publication-title: Hormones (Athens)
  doi: 10.14310/horm.2002.1672
– volume: 32
  start-page: 1171
  year: 2018
  ident: 10.1016/j.nutres.2019.10.009_bb0135
  article-title: GLP-1, a powerful physiological incretin: an update
  publication-title: J Biol Regul Homeost Agents
– volume: 363
  start-page: k4583
  year: 2018
  ident: 10.1016/j.nutres.2019.10.009_bb0150
  article-title: Effects of a low carbohydrate diet on energy expenditure during weight loss maintenance: randomized trial
  publication-title: BMJ
  doi: 10.1136/bmj.k4583
– volume: 57
  start-page: 119
  year: 2010
  ident: 10.1016/j.nutres.2019.10.009_bb0105
  article-title: Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes
  publication-title: Endocr J
  doi: 10.1507/endocrj.K09E-269
– volume: 130
  start-page: 79
  year: 2016
  ident: 10.1016/j.nutres.2019.10.009_bb0140
  article-title: The regulation of function, growth and survival of GLP-1-producing L-cells
  publication-title: Clin Sci (Lond)
  doi: 10.1042/CS20150154
– volume: 93
  start-page: 217
  year: 2018
  ident: 10.1016/j.nutres.2019.10.009_bb0075
  article-title: The role of glucagon in the pathophysiology and treatment of type 2 diabetes
  publication-title: Mayo Clin Proc
  doi: 10.1016/j.mayocp.2017.12.003
– volume: 14
  start-page: 390
  year: 2018
  ident: 10.1016/j.nutres.2019.10.009_bb0030
  article-title: Glucagon-like peptide 1 in health and disease
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/s41574-018-0016-2
– volume: 15
  start-page: 123
  year: 2016
  ident: 10.1016/j.nutres.2019.10.009_bb0085
  article-title: Glucagon and heart in type 2 diabetes: new perspectives
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/s12933-016-0440-3
– volume: 65
  start-page: 3473
  year: 2016
  ident: 10.1016/j.nutres.2019.10.009_bb0115
  article-title: Insulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation
  publication-title: Diabetes
  doi: 10.2337/db16-0240
– volume: 100
  start-page: 42
  year: 2018
  ident: 10.1016/j.nutres.2019.10.009_bb0080
  article-title: Glucagon receptor signaling in metabolic diseases
  publication-title: Peptides
  doi: 10.1016/j.peptides.2017.11.016
SSID ssj0017133
Score 2.247571
Snippet Little is known about postprandial release of serum ghrelin, glucagon, and glucagon-like peptide-1 (GLP-1) in relation with differing fasting insulin levels....
SourceID swepub
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 111
SubjectTerms beverages
blood serum
Carbohydrate content
carbohydrate metabolism disorders
carbohydrates
cross-over studies
energy
fasting
Ghrelin
Glucagon
Glucagon-like peptide-1
insulin
insulin resistance
Meal distribution
men
protein content
Satiety
statistical models
statistics
women
Title Subjects with high fasting insulin also have higher postprandial GLP-1 and glucagon levels than controls with lower insulin
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0271531719305214
https://dx.doi.org/10.1016/j.nutres.2019.10.009
https://www.ncbi.nlm.nih.gov/pubmed/31759769
https://www.proquest.com/docview/2317971574
https://www.proquest.com/docview/2352445701
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-163259
Volume 72
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1879-0739
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017133
  issn: 1879-0739
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier ScienceDirect Freedom Collection Journals
  customDbUrl:
  eissn: 1879-0739
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017133
  issn: 1879-0739
  databaseCode: AIKHN
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Complete Freedom Collection [SCCMFC]
  customDbUrl:
  eissn: 1879-0739
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017133
  issn: 1879-0739
  databaseCode: ACRLP
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection
  customDbUrl:
  eissn: 1879-0739
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017133
  issn: 1879-0739
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1879-0739
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017133
  issn: 1879-0739
  databaseCode: AKRWK
  dateStart: 19810101
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLWm7YUXBBsfHWwyEtqb1zix4-ax2hjlq0KCob1ZjutsmUJStSkSmrTfzr2JHQkQDPHWOLbT1NfXx7fnHhPyMgMHOLHcMdSeYyKGT5lylqk0sxMA5JEzuFH8ME9n5-LthbzYIichFwZpld739z6989a-ZOx_zfGyLMefYEMF05UrgCCYgYqaoKj-BTZ9fDvQPDhuwro4i-IMa4f0uY7jVW8wIQMJXtlxx_HK_rQ8_Q4_f9EW7dajswfkvgeSdNp_14dky9W7ZG9awyb663d6RDtqZxcz3yWj09K1UOZFQCs6Dxr8e-QGXAfGYtYUQ7IU5YtpYdbIhqaeqE7BRBt6Zb657rZb0WWzbpcrzIiBzl6__8g4hQuK_Hdz2dS0QirSmmJYnnoyvO-_wlPZQsePyPnZq88nM-ZPZGBWJnHLikgaaQoj3MRFqNUmVFpYk3Kb2wWPiyTOCgeIRtg4tUUOaKIA_JVHViDfHLzJY7JdN7V7SqiQE5VwpyS3Tihp88jE3GTCLsTC8kSOSBIGQlsvV46nZlQ68NKudT98GocPS2H4RoQNrZa9XMcd9WUYYx1SUcF5alhP7minhnY_mes_tHwRTEnDTMa_Z0ztmg1UAuvMwKSV-FsdCXhMqoiPyJPeDof3RCQI4BKecNQb5nAHJcRPyy9T3awudVVuNIBw2Pbu__dLPCP38Kqn9Twn2-1q4w4AnLX5YTf7DsnO9M272fwHhkE6aw
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwED6N7gFeEGzAyk8job2FxokdN4_VxuhYVyGxob1ZruuMoJBUbYqE-Oe5S5xIgGCIt8T2OU3vfP7sfHcGeJWiAxxb7gLKPReICK9S5WygktSOEZCHztBC8XyeTC_Fuyt5tQNHXSwM0Sq97299euOtfcnI_5ujVZ6PPuCCCocrVwhBKAJV3IJdIdEnD2B3cno2nfcfE2gd1my1KB6QQBdB19C8yi3FZBDHK33d0LzSP81QvyPQX9KLNlPSyT2467Ekm7Q_9z7suHIP9iclrqO_fGOHrGF3NtvmezA8zl2NZT4PaMHmXRr-ffiO3oO2YzaMdmUZZTBmmdkQIZp5rjpDK63YJ_PVNdVuzVbVpl6tKSgGO3s7ex9whjeMKPDmuipZQWykDaOdeeb58L7_gg5m6zp-AJcnby6OpoE_lCGwMo7qIAulkSYzwo1dSOnahEoyaxJuF3bJoyyO0swhqBE2Smy2QECRIQRbhFYQ5RwdykMYlFXpDoAJOVYxd0py64SSdhGaiJtU2KVYWh7LIcSdIrT1Gcvp4IxCd9S0z7pVnyb1USmqbwhBL7VqM3bc0F52OtZdNCr6T41Tyg1yqpf7yWL_QfJlZ0oaBzN9oTGlq7bYCK0zRatW4m9tJEIyqUI-hEetHfbvSWAQ8SU-4bA1zL6Gsogf5x8nulpf6yLfasThuPJ9_N8v8QJuTy_OZ3p2Oj97AneopmX5PIVBvd66Z4jV6sVzPxZ_ABF0PRY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Subjects+with+high+fasting+insulin+also+have+higher+postprandial+GLP-1+and+glucagon+levels+than+controls+with+lower+insulin&rft.jtitle=Nutrition+research+%28New+York%2C+N.Y.%29&rft.au=Albinsson-Stenholm%2C+Erina&rft.au=Bergs%C3%A9n%2C+Johannes&rft.au=Ingves%2C+Simon&rft.au=Vilhelmsson%2C+Nathalie&rft.date=2019-12-01&rft.issn=0271-5317&rft.volume=72&rft.spage=111&rft.epage=120&rft_id=info:doi/10.1016%2Fj.nutres.2019.10.009&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_nutres_2019_10_009
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0271-5317&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0271-5317&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0271-5317&client=summon